HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids after transplant: safer GVHD prevention?
Disease control TerminatedThis study looked at a new way to prevent severe graft-versus-host disease (GVHD) in children who had a bone marrow transplant for blood cancers. The goal was to see if stopping certain immune-suppressing drugs early could lower the risk of severe GVHD. Only 3 children took part …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Radiation after failed CAR t: a tiny pilot that stopped early
Disease control TerminatedThis small pilot study tested whether adding radiation therapy could help people with lymphoma that did not respond to CAR T cell therapy. Only 3 people took part, and the study was stopped early. The main goal was to check safety and side effects, not to prove the treatment work…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New antibiotic tackles tough infections in vulnerable patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam for serious Pseudomonas aeruginosa infections in people with blood cancers or who had a stem cell transplant. Participants received the drug through a vein for 10 to 14 days. Researchers tracked whether patients were alive a…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New drug BR108 tested in blood cancer patients – early results expected
Disease control TerminatedThis early-stage study tested a new drug called BR108 in 8 adults with advanced blood cancers (lymphoma, leukemia, or myelodysplastic syndrome) that had not responded to other treatments. The main goals were to check safety, find the right dose, and see if the drug could shrink t…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
PET scan may spot silent heart danger in cancer patients
Diagnosis TerminatedThis small pilot study tested whether a special PET scan can find hidden heart inflammation in people receiving immune checkpoint inhibitors (a type of cancer immunotherapy). The goal was to see if this inflammation could be caught early before it becomes serious. Only 2 people t…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 15, 2026 11:56 UTC